2340 related articles for article (PubMed ID: 25838374)
1. Adoptive cell transfer as personalized immunotherapy for human cancer.
Rosenberg SA; Restifo NP
Science; 2015 Apr; 348(6230):62-8. PubMed ID: 25838374
[TBL] [Abstract][Full Text] [Related]
2. Treating cancer with genetically engineered T cells.
Park TS; Rosenberg SA; Morgan RA
Trends Biotechnol; 2011 Nov; 29(11):550-7. PubMed ID: 21663987
[TBL] [Abstract][Full Text] [Related]
3. Adoptive T-Cell Therapy for Cancer.
Yang JC; Rosenberg SA
Adv Immunol; 2016; 130():279-94. PubMed ID: 26923004
[TBL] [Abstract][Full Text] [Related]
4. An Update on Adoptive T-Cell Therapy and Neoantigen Vaccines.
Ott PA; Dotti G; Yee C; Goff SL
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e70-e78. PubMed ID: 31099621
[TBL] [Abstract][Full Text] [Related]
5. Adoptive-cell-transfer therapy for the treatment of patients with cancer.
Dudley ME; Rosenberg SA
Nat Rev Cancer; 2003 Sep; 3(9):666-75. PubMed ID: 12951585
[TBL] [Abstract][Full Text] [Related]
6. Genetic redirection of T cells for cancer therapy.
Westwood JA; Kershaw MH
J Leukoc Biol; 2010 May; 87(5):791-803. PubMed ID: 20179152
[TBL] [Abstract][Full Text] [Related]
7. Adoptive cell transfer for patients with metastatic melanoma: the potential and promise of cancer immunotherapy.
Phan GQ; Rosenberg SA
Cancer Control; 2013 Oct; 20(4):289-97. PubMed ID: 24077405
[TBL] [Abstract][Full Text] [Related]
8. Chimeric switch receptor: switching for improved adoptive T-cell therapy against cancers.
Tay JC; Zha S; Wang S
Immunotherapy; 2017 Dec; 9(16):1339-1349. PubMed ID: 29185393
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer.
Marcus A; Eshhar Z
Expert Opin Biol Ther; 2014 Jul; 14(7):947-54. PubMed ID: 24661086
[TBL] [Abstract][Full Text] [Related]
10. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.
Lauss M; Donia M; Harbst K; Andersen R; Mitra S; Rosengren F; Salim M; Vallon-Christersson J; Törngren T; Kvist A; Ringnér M; Svane IM; Jönsson G
Nat Commun; 2017 Nov; 8(1):1738. PubMed ID: 29170503
[TBL] [Abstract][Full Text] [Related]
11. Personalized Therapy: Tumor Antigen Discovery for Adoptive Cellular Therapy.
Yee C; Lizee GA
Cancer J; 2017; 23(2):144-148. PubMed ID: 28410303
[TBL] [Abstract][Full Text] [Related]
12. Unleash the power of the mighty T cells-basis of adoptive cellular therapy.
Sukari A; Abdallah N; Nagasaka M
Crit Rev Oncol Hematol; 2019 Apr; 136():1-12. PubMed ID: 30878123
[TBL] [Abstract][Full Text] [Related]
13. Redirected T cells in cancer therapy.
Sangiolo D
Expert Opin Biol Ther; 2015; 15(12):1667-70. PubMed ID: 26515608
[TBL] [Abstract][Full Text] [Related]
14. CCR 20th Anniversary Commentary: Autologous T Cells-The Ultimate Personalized Drug for the Immunotherapy of Human Cancer.
Rosenberg SA
Clin Cancer Res; 2015 Dec; 21(24):5409-11. PubMed ID: 26672082
[TBL] [Abstract][Full Text] [Related]
15. Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons.
Zhao Q; Jiang Y; Xiang S; Kaboli PJ; Shen J; Zhao Y; Wu X; Du F; Li M; Cho CH; Li J; Wen Q; Liu T; Yi T; Xiao Z
Front Immunol; 2021; 12():658753. PubMed ID: 33859650
[TBL] [Abstract][Full Text] [Related]
16. T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.
Ikeda H
Int Immunol; 2016 Jul; 28(7):349-53. PubMed ID: 27127191
[TBL] [Abstract][Full Text] [Related]
17. Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy.
Nissani A; Lev-Ari S; Meirson T; Jacoby E; Asher N; Ben-Betzalel G; Itzhaki O; Shapira-Frommer R; Schachter J; Markel G; Besser MJ
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33990415
[TBL] [Abstract][Full Text] [Related]
18. Prospects for gene-engineered T cell immunotherapy for solid cancers.
Klebanoff CA; Rosenberg SA; Restifo NP
Nat Med; 2016 Jan; 22(1):26-36. PubMed ID: 26735408
[TBL] [Abstract][Full Text] [Related]
19. [Principles of adoptive cell therapy based on "Tumor Infiltrating Lymphocytes"].
Martins F; Orcurto A; Michielin O; Coukos G
Rev Med Suisse; 2016 May; 12(519):989-93. PubMed ID: 27424426
[TBL] [Abstract][Full Text] [Related]
20. The adoptive transfer of cultured T cells for patients with metastatic melanoma.
Yang JC
Clin Dermatol; 2013; 31(2):209-19. PubMed ID: 23438384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
